Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
29.49
+0.83 (2.90%)
At close: Dec 19, 2025, 4:00 PM EST
29.31
-0.18 (-0.61%)
After-hours: Dec 19, 2025, 5:11 PM EST

AAPG Revenue

Ascentage Pharma Group International had revenue of 116.85M CNY in the half year ending June 30, 2025, a decrease of -71.63%. This brings the company's revenue in the last twelve months to 390.60M, down -56.75% year-over-year. In the year 2024, Ascentage Pharma Group International had annual revenue of 980.65M with 341.77% growth.

Revenue (ttm)
390.60M CNY
Revenue Growth
-56.75%
P/S Ratio
48.87
Revenue / Employee
688,894 CNY
Employees
567
Market Cap
2.66B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024980.65M758.67M341.77%
Dec 31, 2023221.98M12.27M5.85%
Dec 31, 2022209.71M181.80M651.38%
Dec 31, 202127.91M15.46M124.18%
Dec 31, 202012.45M-2.06M-14.21%
Dec 31, 201914.51M7.71M113.21%
Dec 31, 20186.81M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

AAPG News

More News